NFE2L2 and asthma: In this role, Nrf2 activity has been shown to be an important disease modifier in many oxidative/inflammatory diseases, such as asthma, sepsis, and pulmonary fibrosis, in which decreased Nrf2 activity exacerbates disease progression [14-16].